Just Internal Medicine

25/12/2024

📢 New European Hematology Association (EHA)–ESMO (CPG) on HIV-associated .

HIV-associated lymphomas are not just lymphomas: This multidisciplinary, collaborative effort aims to provide practical recommendations to clinicians managing in people who are positive and covers clinical, imaging and pathological diagnosis, staging and risk assessment, treatment and follow-up.

Check it now: 🔗 https://ow.ly/iSGX50TcXJG

25/12/2024

📣 New ESMO recommendations in : fruquitinib in chemorefractory patients and the use of KRAS G12C inhibitors.


🔗 https://ow.ly/aIjK50Uhx9i

25/12/2024

📣 ESMO eUpdate on in a rapidly evolving landscape: new recommendations on , local therapies for locally advanced tumours and systemic therapies for recurrent/metastatic disease.


🔗 https://ow.ly/PYK150UpIxz

25/12/2024

📣 Updated ESMO on : New recommendations include for and options for advanced disease based on (neo)adjuvant treatment, disease and patient characteristics.

🔗https://ow.ly/KIga50U5876

26/07/2024

26/07/2024

🔴Atrial Fibrillation: Rate vs Rhythm control in 2024
🔹Younger age
🔹 Smaller left atrium
🔹 Symptomatic in afib
🔹 Lower EF
🔹 Shorter history of afib
—> all factors favoring rhythm control over rate control
🔹Rationale for more aggressive rhythm control: That maladaptive atrial remodeling with afib leads to more afib … afib begets afib

⤵️2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation:
🔹https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017

26/07/2024

🔴⚡️The potential anti-arrhythmic effect of SGLT2 inhibitors

💊 antiarrhythmic mechanisms, pathways involved, and current evidences.

🔹https://cardiab.biomedcentral.com/articles/10.1186/s12933-024-02312-0

26/07/2024

🔴Approach to Hyponatremia! 🧠🔹

⤵️

26/07/2024

15/06/2024

🔴 🫁 ADVANCED THORACIC 🫁

🔸🅰️-Line: Physiologic reflection of pleural line
🔸🅱️-Line: Vertical comet tail artifacts

🔸🦓 Z-line: ill defined artifacts shorter in depth that look like B-lines but aren't

🔸🆎Lung profiles can help with diagnoses

29/05/2024

🔴Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction

https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehae300/7684164?login=false